GO
Loading...

Covidien PLC

More

  • Early Movers: COV, YHOO, GOOG, GE, TGT, T & more Monday, 16 Jun 2014 | 7:46 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures drop as Iraq turmoil continues Monday, 16 Jun 2014 | 7:40 AM ET

    *U.S. considering talks with Iran over Iraq. *Medtronic to buy Covidien for $42.9 bln. *Geopolitical tensions in Ukraine also flared as Russian natural gas exporter Gazprom reduced supplies to Ukraine on Monday after Kiev failed to meet a deadline to pay off its gas debts in a dispute that could disrupt supplies to the rest of Europe.

  • CNBC's Meg Tirrell reports the latest detail on the deal as consolidation in the health care industry continues.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it had agreed to buy Covidien Plc for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it would buy Covidien Plc for $42.9 billion in cash and stock, moving its executive base to Ireland in the latest transaction to seek lower corporate tax rates abroad.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

  • June 14- Medical-device maker Medtronic Inc and rival Covidien Plc are in advanced talks to combine in a deal valued at $45 billion to $50 billion, a source familiar with the matter said on Saturday.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to merge with rival Covidien Plc in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.

  • Medtronic, Covidien in advanced talks to combine -WSJ Saturday, 14 Jun 2014 | 12:23 PM ET

    June 14- Medical-device maker Medtronic Inc and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. Covidien is based in Ireland, which is known for having a relatively low tax rate.

  • NEW YORK, June 9- When the European Central Bank put its economy-boosting stimulus plan into high gear last week, it sent European stock prices to six-year highs.

  • JPMorgan health care pro's top stock picks Monday, 21 Apr 2014 | 7:00 PM ET

    JPMorgan Chase's Mike Weinstein gives his top health care picks to buy right now, in light of recent weakness in the sector.

  • April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.

  • Mallinckrodt pullback a buying opportunity? Monday, 7 Apr 2014 | 6:46 PM ET

    When shares of a good company fall swiftly, Cramer looks to see if the pullback presents opportunity.

  • April 7- Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its lucrative drug to treat multiple sclerosis, Acthar Gel.

  • April 7- Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its lucrative drug to treat multiple sclerosis, Acthar Gel. This acquisition, Mallinckrodt's second deal in less than two months, highlights its efforts to tap into the fast-growing specialty drugs market.

  • Medical appliance stocks: Analyst shares her picks Friday, 4 Apr 2014 | 12:46 PM ET
    An Edwards Lifesciences Corp. SAPIEN transcatheter heart valve is assembled in a training room at company headquarters in Irvine, Calif.

    Shagun Chadha shares her top pick among medical appliance companies and gives other sector names she likes as well.

  • WASHINGTON, March 31- Bariatric weight loss surgery on obese patients with type 2 diabetes helped many to get their blood sugar to healthy levels and to no longer require any diabetes medicines, including insulin, three years after the procedure, according to data presented at a major medical meeting on Monday.

  • Feb 11- Specialty pharmaceuticals company Mallinckrodt Plc said it would buy pain drug maker Cadence Pharmaceuticals Inc for about $1.3 billion to expand in the hospital market, where Cadence's products are widely used.

  • Feb 4- Medtronic Inc's stumble in its U.S. medical device study to treat high blood pressure could create an opportunity for other device makers to pick up where their rival has left off, Boston Scientific Corp Chief Executive Mike Mahoney said on Tuesday.

  • Traders pondering if this US selloff is the big one Friday, 24 Jan 2014 | 11:38 AM ET
    A trader works on the floor of the New York Stock Exchange.

    U.S. stock prices could continue to correct, but it's too soon to say whether this is the big one.